The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mo, A. X. Y.
Right arrow Articles by Rock, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mo, A. X. Y.
Right arrow Articles by Rock, K. L.
The Journal of Immunology, 2000, 164: 4003-4010.
Copyright © 2000 by The American Association of Immunologists

Sequences That Flank Subdominant and Cryptic Epitopes Influence the Proteolytic Generation of MHC Class I-Presented Peptides1

Annie X. Y. Mo, Steven F. L. van Lelyveld2, Abie Craiu3 and Kenneth L. Rock4

Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655

The proteasome has been shown to make the proper C-terminal cleavage for the generation of several immunodominant class I-presented peptides whereas aminopeptidases generate their proper N termini. In this study, we show that these two distinct proteolytic processes are also involved in generating a subdominant OVA peptide KVVRFDKL (K-L). Moreover, proteasome inhibitors did not enhance the presentation of any K-L construct, suggesting that destruction of this peptide by proteasomes, if any, does not limit its presentation. We have further examined in intact cells the influence of residues flanking this epitope on these proteolytic processes. When the N-terminal flanking residues of K-L are fused to an immunodominant OVA peptide SIINFEKL (S-L), the presentation of S-L is reduced as compared with a construct with its natural flanking sequence and was not inhibited (or enhanced) by proteasome inhibitors. Similarly, a reduction in presentation was observed when the C-terminal flanking residues of the subdominant epitope were attached to S-L. A detailed analysis revealed that the Pro at the P1' position of K-L was responsible for this reduction, and presentation of these C-terminally extended constructs was sensitive to proteasome inhibitor. The study suggests that both the N- and C-terminal flanks of the subdominant peptide are suboptimal for Ag presentation. Moreover, three of four C-terminal residues that flank other subdominant or cryptic epitopes in OVA reduced the presentation of S-L. Therefore, the residues that flank the C termini of several subdominant and cryptic epitopes are often suboptimal for cleavage and may contribute to the phenomenon of immunodominance.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
C. F. Towne, I. A. York, L. B. Watkin, J. S. Lazo, and K. L. Rock
Analysis of the Role of Bleomycin Hydrolase in Antigen Presentation and the Generation of CD8 T Cell Responses
J. Immunol., June 1, 2007; 178(11): 6923 - 6930.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Liu, B. A. Ewald, D. M. Lynch, A. Nanda, S. M. Sumida, and D. H. Barouch
Modulation of DNA Vaccine-Elicited CD8+ T-Lymphocyte Epitope Immunodominance Hierarchies
J. Virol., December 15, 2006; 80(24): 11991 - 11997.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Otahal, S. C. Hutchinson, L. M. Mylin, M. J. Tevethia, S. S. Tevethia, and T. D. Schell
Inefficient Cross-Presentation Limits the CD8+ T Cell Response to a Subdominant Tumor Antigen Epitope
J. Immunol., July 15, 2005; 175(2): 700 - 712.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
E. J. Cheadle, D. O'Donnell, P. J. Selby, and A. M. Jackson
Closely Related Mycobacterial Strains Demonstrate Contrasting Levels of Efficacy as Antitumor Vaccines and Are Processed for Major Histocompatibility Complex Class I Presentation by Multiple Routes in Dendritic Cells
Infect. Immun., February 1, 2005; 73(2): 784 - 794.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Chapatte, C. Servis, D. Valmori, O. Burlet-Schiltz, J. Dayer, B. Monsarrat, P. Romero, and F. Levy
Final Antigenic Melan-A Peptides Produced Directly by the Proteasomes Are Preferentially Selected for Presentation by HLA-A*0201 in Melanoma Cells
J. Immunol., November 15, 2004; 173(10): 6033 - 6040.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Q. Lou, R. J. Kelleher Jr, A. Sette, J. Loyall, S. Southwood, R. B. Bankert, and S. H. Bernstein
Germ line tumor-associated immunoglobulin VH region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells
Blood, August 1, 2004; 104(3): 752 - 759.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kan-Mitchell, B. Bisikirska, F. Wong-Staal, K. L. Schaubert, M. Bajcz, and M. Bereta
The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope
J. Immunol., May 1, 2004; 172(9): 5249 - 5261.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
R. Draenert, S. Le Gall, K. J. Pfafferott, A. J. Leslie, P. Chetty, C. Brander, E. C. Holmes, S.-C. Chang, M. E. Feeney, M. M. Addo, et al.
Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection
J. Exp. Med., April 5, 2004; 199(7): 905 - 915.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Ali, R. Lubong, H. Ng, D. G. Brooks, J. A. Zack, and O. O. Yang
Impacts of Epitope Expression Kinetics and Class I Downregulation on the Antiviral Activity of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes
J. Virol., January 15, 2004; 78(2): 561 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
G. Dadaglio, S. Morel, C. Bauche, Z. Moukrim, F. A. Lemonnier, B. J. Van den Eynde, D. Ladant, and C. Leclerc
Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes
Int. Immunol., December 1, 2003; 15(12): 1423 - 1430.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Li, M. A. Haque, and J. S. Blum
Role of Disulfide Bonds in Regulating Antigen Processing and Epitope Selection
J. Immunol., September 1, 2002; 169(5): 2444 - 2450.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. S. Kawamura, R.-C. Su, L. T. Nguyen, A. R. Elford, P. S. Ohashi, and J. Gariepy
In Vivo Generation of Cytotoxic T Cells from Epitopes Displayed on Peptide-Based Delivery Vehicles
J. Immunol., June 1, 2002; 168(11): 5709 - 5715.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. C. M. Boon, G. de Mutsert, Y. M. F. Graus, R. A. M. Fouchier, K. Sintnicolaas, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan
The Magnitude and Specificity of Influenza A Virus-Specific Cytotoxic T-Lymphocyte Responses in Humans Is Related to HLA-A and -B Phenotype
J. Virol., January 15, 2002; 76(2): 582 - 590.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. M. Gray, G. D. Parks, and M. A. Alexander-Miller
A Novel CD8-Independent High-Avidity Cytotoxic T-Lymphocyte Response Directed against an Epitope in the Phosphoprotein of the Paramyxovirus Simian Virus 5
J. Virol., November 1, 2001; 75(21): 10065 - 10072.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Knuehl, P. Spee, T. Ruppert, U. Kuckelkorn, P. Henklein, J. Neefjes, and P.-M. Kloetzel
The Murine Cytomegalovirus pp89 Immunodominant H-2Ld Epitope Is Generated and Translocated into the Endoplasmic Reticulum as an 11-Mer Precursor Peptide
J. Immunol., August 1, 2001; 167(3): 1515 - 1521.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.